Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 789 results found. Search for [ US health regulator ]

Results 60 to 80 of 789
Reuters
December 17, 2020
The adverse reaction in the person, minutes after taking the Pfizer shot on Tuesday, was similar to two cases reported last week in Britain


BusinessToday.In
December 13, 2020
Dr Randeep Guleria, the head of All India Institute of Medical Sciences (AIIMS), is reportedly heading the team that's preparing the list of patients.


BusinessToday.In
December 13, 2020
David Prior says next three months are going to be extremely difficult and the world is pinning hopes on vaccine; Serum Institute also hopes to get approval for emergency use in India soon after nod in the UK


Anshula Raj
December 10, 2020
Both Pfizer and Moderna have admitted that taking their vaccines could result in side-effects similar to mild Covid symptoms such as muscle pain, chills and a headache


PB Jayakumar
December 10, 2020
Though Pfizer India says it remains committed to advance dialogue with Indian government to make the vaccine available for use, experts believe it will be difficult for its parent to supply adequate quantities of the vaccine


BusinessToday.In
December 9, 2020
Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa


Rashi Bisaria
New Delhi, December 9, 2020
DCGI actively considering 3 COVID-19 vaccines for emergency use: Health Ministry Three COVID-19 vaccines candidates, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration by India's drug regulator and there is hope that getting an early license might be possible for all or any of them, the Union health ministry said on Tuesday. Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderab...


Reuters
December 9, 2020
Asian shares hit record high and US stock futures gained on Wednesday as investors tracked positive news on COVID-19 vaccines


BusinessToday.In
December 9, 2020
India Stock Market Highlights Today: Intraday, both indices touched all time highs today, with Sensex hitting 46,164 and Nifty touching 13,548.


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


Joe C Mathew
December 7, 2020
Both companies have applied for vaccine approval, following which, these companies will be able to supply vaccines to the central government to begin its multi-phase vaccination of Indian residents against the COVID-19


BusinessToday.In
December 7, 2020
Pfizer's clarification comes as experts believe that storing the vaccine in minus 70 degree Celsius would be a big hurdle


BusinessToday.In
December 4, 2020
India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280


Aprajita Sharma
December 2, 2020
The top two players - Zerodha and Upstox - now have over 26 lakh and nearly 14 lakh active clients, respectively on the NSE as of October-end, while ICICI Securities has 12.15 lakh clients


Sonal Khetarpal
December 2, 2020
Honey samples from leading brands such as Dabur, Patanjali, Baidyanath, Zandu, Hitkari and Apis Himalaya, all failed the NMR test


Sumant Banerji
December 2, 2020
The brands whose samples flunked the test include household names like Dabur, yoga guru Ramdev Baba's Patanjali, Zandu, Baidyanath, Apis Himalaya and Hitkari


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 22, 2020
USFDA Commissioner Stephen Hahn said that USFDA has been preparing for review of EUAs for COVID-19 vaccines for the past several months and requests will be processed \"as expeditiously as possible\"


PAGES 4 OF 40  12345